From a large-sample size analysis, we discovered and validated 2 protein peaks, B2M (11.7 kDa) and CC16 (15.8 kDa), as biomarkers associated with nephropathy and verified the discriminatory ability in a set of 238 individuals including diabetic and nondiabetic patients. This evidence concerns the gene SCGB1A1 and Nephropathy.